Home / Specialties / Nephrology (page 3)

Nephrology

Nephrology and Kidney Care for Diabetics: Diabetes causes tremendous stress and damage to the kidneys. Diabetes patients are frequently renally impaired and at high risk for kidney failure if not on dialysis. This further complicates the management of their diabetes and increases mortality risk. However, new treatments, drugs, and clinical insights are aiding medical professionals in their fight against kidney disease and its relationship to diabetes.

GLP‑1s in Advanced CKD and Dialysis: How Far Can We Go Safely?

GLP-1 injection pen with kidney model and dialysis tubing illustrating treatment in advanced CKD and dialysis patients

Managing type 2 diabetes in people with advanced chronic kidney disease (CKD) and end-stage kidney disease (ESKD) on dialysis presents unique clinical challenges. With the 2026 Standards of Care increasingly shifting the focus toward cardio-renal outcomes, many clinicians are asking: how far can we go safely with GLP‑1 receptor agonists …

Read More »

Kidney Protection in Diabetes: Using SGLT2s and GLP‑1s Early

Medical illustration comparing a healthy kidney and a diabetic kidney, with diabetes care tools like a glucometer and GLP‑1 medication in the background, emphasizing kidney protection in diabetes.

  As the burden of diabetic kidney disease (DKD) continues to grow, so does the urgency for early, evidence-based interventions. The concept of kidney protection diabetes is shifting—clinicians are now encouraged to initiate therapy before substantial kidney function loss occurs. Two major drug classes—SGLT2 inhibitors and GLP‑1 receptor agonists—are leading …

Read More »

Cardiorenal-Metabolic Disease in Focus: Applying the CKM Framework in Diabetes Practice

Composite image showing cardiovascular, kidney, and metabolic health tools including glucometer, medications, and a CKM concept diagram on a doctor’s desk.

The CKM framework in diabetes care—focusing on cardiovascular, kidney, and metabolic health—is more than a trend. It’s a clinical necessity. The ADA’s 2025 Standards of Care urge clinicians to manage these overlapping risks together, not separately. Why? Because patients with diabetes deserve outcomes that go beyond just A1C. This article …

Read More »

When Diabetes Isn’t the Main Problem: Managing Comorbidities Without Losing Focus

Medical stethoscope, glucose meter, and a clipboard showing icons for heart, kidneys, and brain, symbolizing comorbidities in type 2 diabetes management.

Living with type 2 diabetes often means managing more than just blood glucose. For many patients, conditions like cardiovascular disease, chronic kidney disease, or depression take center stage in their care plan. When diabetes isn’t the main problem, how do you keep glucose control on track without compromising treatment for …

Read More »

The Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone: A New Option for Patients with Diabetic Kidney Disease

Allison S. Rembert, PharmD Candidate 2024 Adrian K. Baker, PharmD Candidate 2024 Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 55-year-old female with type 2 diabetes (T2D) and chronic kidney disease (CKD) presented to the ambulatory care clinic. …

Read More »